US Map / Nevada
State NV

Clinical Trials in Nevada

Nevada is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Nevada and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 85 actively recruiting studies with Nevada sites out of 85 registered in total. The busiest research areas in Nevada are Obesity, Breast Cancer, Acute Myeloid Leukemia. Leading sponsors running trials in the state include AstraZeneca, Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network. By stage, Nevada trials break down as Phase 1 (7), Phase 2 (22), Phase 3 (40), Phase 4 (6).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
85
Recruiting Now
85
← Back to US Map
Top Conditions in Nevada
Obesity (3)Breast Cancer (3)Acute Myeloid Leukemia (3)Endometrial Cancer (3)Systemic Lupus Erythematosus (2)ADHD (2)Overweight (2)Crohn's Disease (2)Atherosclerotic Cardiovascular Disease (1)Major Depressive Disorder (MDD) (1)Diabetic Retinopathy (1)Anatomic Stage IV Breast Cancer AJCC v8 (1)

Frequently Asked Questions — Clinical Trials in Nevada

How many clinical trials are currently recruiting in Nevada?
ClinicalMetric currently tracks 85 actively recruiting clinical trials with at least one location in Nevada. The total number of registered studies—including active but not currently enrolling trials—is 85. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Nevada?
Nevada hosts clinical trials across a broad range of medical conditions, including Obesity, Breast Cancer, Acute Myeloid Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Nevada serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Nevada?
To join a clinical trial in Nevada, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Nevada maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Nevada

NCT07218809 Phase 3
Recruiting
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy i...
Condition
Epithelial Ovarian Cancer
Enrollment
1,100 pts
Location
United States, Australia, Belgium
Sponsor
AstraZeneca
View Trial →
NCT07172516 Phase 3
Recruiting
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associat...
Condition
Bipolar Disorder
Enrollment
400 pts
Location
United States, Bulgaria, Germany
Sponsor
Xenon Pharmaceuticals Inc.
View Trial →
NCT06246916 Phase 3
Recruiting
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Partic...
Condition
Melanoma
Enrollment
560 pts
Location
United States, Canada
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT05183035 Phase 3
Recruiting
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Condition
Acute Myeloid Leukemia
Enrollment
130 pts
Location
United States, Australia, Austria
Sponsor
PedAL BCU, LLC
View Trial →
NCT07064473 Phase 3
Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empag...
Condition
Diabetes Mellitus, Type 2
Enrollment
11,800 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT00358943 N/A
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Preg...
Condition
Gaucher Disease
Enrollment
12,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
View Trial →
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07709819 N/A
Recruiting
A Nanoscopic Second Look Into the Knee Joint
Condition
Meniscal Tears
Enrollment
15 pts
Location
United States
Sponsor
Angelina Vera MD
View Trial →
NCT07100080 Phase 2, Phase 3
Recruiting
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGF...
Condition
Non-Small Cell Lung Cancer
Enrollment
500 pts
Location
United States, Argentina, Belgium
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06857942 Phase 4
Recruiting
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following In...
Condition
Psoriasis
Enrollment
200 pts
Location
United States
Sponsor
Eli Lilly and Company
View Trial →
NCT01574053 N/A
Recruiting
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Condition
Huntington's Disease
Enrollment
35,000 pts
Location
United States, Argentina, Australia
Sponsor
CHDI Foundation, Inc.
View Trial →
NCT07190222 Phase 3
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in ...
Condition
Chronic Obstructive Pulmonary Disease
Enrollment
942 pts
Location
United States, Argentina, Australia
Sponsor
Sanofi
View Trial →
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT06662162 N/A
Recruiting
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-r...
Condition
Age-Related Macular Degeneration
Enrollment
100 pts
Location
United States, Australia, New Zealand
Sponsor
i-Lumen Scientific AUS PTY LTD
View Trial →
NCT04781140 Phase 4
Recruiting
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Chi...
Condition
Attention-Deficit/Hyperactivity Disorder
Enrollment
286 pts
Location
United States
Sponsor
Supernus Pharmaceuticals, Inc.
View Trial →
NCT06116682 Phase 2
Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Co...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
88 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT06499285 Phase 3
Recruiting
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermed...
Condition
Myelodysplastic Syndromes
Enrollment
225 pts
Location
United States, Australia, Brazil
Sponsor
Takeda
View Trial →
NCT06680830 Phase 2
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Posi...
Condition
Parkinson Disease
Enrollment
150 pts
Location
United States, Israel, Italy
Sponsor
Neuron23 Inc.
View Trial →
NCT07227012 Phase 1, Phase 2
Recruiting
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a S...
Condition
Carcinoma, Hepatocellular
Enrollment
138 pts
Location
United States, Japan, Puerto Rico
Sponsor
Pfizer
View Trial →
NCT07062965 Phase 3
Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With...
Condition
Breast Cancer
Enrollment
400 pts
Location
United States, Australia, Belgium
Sponsor
Pfizer
View Trial →
NCT06884865 Phase 2
Recruiting
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful O...
Condition
Osteoarthritis (OA) of the Knee
Enrollment
135 pts
Location
United States
Sponsor
Pacira Pharmaceuticals, Inc
View Trial →
NCT05647265 Phase 2
Recruiting
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomato...
Condition
Pleural Biphasic Mesothelioma
Enrollment
26 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT07380412 N/A
Recruiting
A Study to Evaluate the Effects of a Supplement on the Side Effects Associated W...
Condition
ADHD
Enrollment
90 pts
Location
United States
Sponsor
Outliers, Inc.
View Trial →
NCT06868212 Phase 3
Recruiting
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Time...
Condition
Chronic Spontaneous Urticaria (CSU)
Enrollment
400 pts
Location
United States
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06207032 N/A
Recruiting
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Condition
Cancer
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
Tempus AI
View Trial →
Page 3 of 4 — 85 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology